Molecules/SERIBANTUMAB

SERIBANTUMAB

Molecular Identity

AntibodyPhase 2

Mechanism of action: Receptor tyrosine-protein kinase erbB-3 antagonist

Molecular Formula

0.00

Molecular Weight

g/mol

MM-121MM121SAR-256212SAR256212SERIBANTUMAB

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to SERIBANTUMAB

Loading drug network...